Palisade Bio, Inc.
PALI· Nasdaq
PALIPalisade Bio, Inc.
Released Aug 13, 2020, during market hours
10-Q filed Aug 13, 2020, 44 days after period end · 0001171843-20-005880
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2020 | Q2 2019 | Q2 2018 | Q2 2017 |
|---|---|---|---|---|
| Revenue | $2.50K | $7.89K | $252.50K | $2.50K |
| Net Income | -$1.85M | -$1.44M | -$627.05K | -$4.65M |
| EPS Diluted | -$0.67 |
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR
| -$1.45 |
| -$0.83 |
| -$0.39 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
